OpenURL Connection Search

Select item for more details and to access through your institution.

Transcriptomic profiles and 5-year results from the randomized CLL14 study of venetoclax plus obinutuzumab versus chlorambucil plus obinutuzumab in chronic lymphocytic leukemia.
Published in:
Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-37648-w
By:
- Al-Sawaf, Othman;
- Zhang, Can;
- Jin, Hyun Yong;
- Robrecht, Sandra;
- Choi, Yoonha;
- Balasubramanian, Sandhya;
- Kotak, Alex;
- Chang, Yi Meng;
- Fink, Anna Maria;
- Tausch, Eugen;
- Schneider, Christof;
- Ritgen, Matthias;
- Kreuzer, Karl-Anton;
- Chyla, Brenda;
- Paulson, Joe;
- Pallasch, Christian P.;
- Frenzel, Lukas P.;
- Peifer, Martin;
- Eichhorst, Barbara;
- Stilgenbauer, Stephan
Publication type:
Article
Immunological Barriers to Embryonic Stem Cell-Derived Therapies.
Published in:
Cells Tissues Organs, 2008, v. 188, n. 1/2, p. 78, doi. 10.1159/000118784
By:
- Šarić, Tomo;
- Frenzel, Lukas P.;
- Hescheler, Jürgen
Publication type:
Article
Role of Natural-Killer Group 2 Member D Ligands and Intercellular Adhesion Molecule 1 in Natural Killer Cell-Mediated Lysis of Murine Embryonic Stem Cells and Embryonic Stem Cell-Derived Cardiomyocytes.
Published in:
Stem Cells, 2009, v. 27, n. 2, p. 307, doi. 10.1634/stemcells.2008-0528
By:
- Frenzel, Lukas P.;
- Abdullah, Zeinab;
- Kriegeskorte, Anja K.;
- Dieterich, Rebecca;
- Lange, Nadin;
- Busch, Dirk H.;
- Krönke, Martin;
- Utermöhlen, Olaf;
- Hescheler, Jürgen;
- Šarića, Tomo
Publication type:
Article
BCL‐2‐family protein tBID can act as a BAX‐like effector of apoptosis.
Published in:
EMBO Journal, 2022, v. 41, n. 2, p. 1, doi. 10.15252/embj.2021108690
By:
- Flores‐Romero, Hector;
- Hohorst, Lisa;
- John, Malina;
- Albert, Marie‐Christine;
- King, Louise E;
- Beckmann, Laura;
- Szabo, Tamas;
- Hertlein, Vanessa;
- Luo, Xu;
- Villunger, Andreas;
- Frenzel, Lukas P;
- Kashkar, Hamid;
- Garcia‐Saez, Ana J
Publication type:
Article
Author Correction: Transcriptomic profiles and 5-year results from the randomized CLL14 study of venetoclax plus obinutuzumab versus chlorambucil plus obinutuzumab in chronic lymphocytic leukemia.
Published in:
2023
By:
- Al-Sawaf, Othman;
- Zhang, Can;
- Jin, Hyun Yong;
- Robrecht, Sandra;
- Choi, Yoonha;
- Balasubramanian, Sandhya;
- Kotak, Alex;
- Chang, Yi Meng;
- Fink, Anna Maria;
- Tausch, Eugen;
- Schneider, Christof;
- Ritgen, Matthias;
- Kreuzer, Karl-Anton;
- Chyla, Brenda;
- Paulson, Joseph N.;
- Pallasch, Christian P.;
- Frenzel, Lukas P.;
- Peifer, Martin;
- Eichhorst, Barbara;
- Stilgenbauer, Stephan
Publication type:
Correction Notice
Transcriptomic profiles and 5-year results from the randomized CLL14 study of venetoclax plus obinutuzumab versus chlorambucil plus obinutuzumab in chronic lymphocytic leukemia.
Published in:
Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-37648-w
By:
- Al-Sawaf, Othman;
- Zhang, Can;
- Jin, Hyun Yong;
- Robrecht, Sandra;
- Choi, Yoonha;
- Balasubramanian, Sandhya;
- Kotak, Alex;
- Chang, Yi Meng;
- Fink, Anna Maria;
- Tausch, Eugen;
- Schneider, Christof;
- Ritgen, Matthias;
- Kreuzer, Karl-Anton;
- Chyla, Brenda;
- Paulson, Joseph N.;
- Pallasch, Christian P.;
- Frenzel, Lukas P.;
- Peifer, Martin;
- Eichhorst, Barbara;
- Stilgenbauer, Stephan
Publication type:
Article
Concepts of Chronic Lymphocytic Leukemia Pathogenesis: DNA Damage Response and Tumor Microenvironment.
Published in:
Oncology Research & Treatment, 2016, v. 39, n. 1/2, p. 9, doi. 10.1159/000443820
By:
- Frenzel, Lukas P.;
- Reinhardt, H. Christian;
- Pallasch, Christian P.
Publication type:
Article
Post‐transplant‐cyclophosphamide and short‐term Everolimus as graft‐versus‐host‐prophylaxis in patients with relapsed/refractory lymphoma and myeloma—Final results of the phase II OCTET‐EVER trial.
Published in:
European Journal of Haematology, 2024, v. 113, n. 2, p. 163, doi. 10.1111/ejh.14210
By:
- Richardson, Tim;
- Scheid, Christof;
- Herling, Marco;
- Frenzel, Lukas P.;
- Herling, Carmen;
- Aguilar, Marta Rebecca Cruz;
- Theurich, Sebastian;
- Hallek, Michael;
- Holtick, Udo
Publication type:
Article
Two mouse models reveal an actionable PARP1 dependence in aggressive chronic lymphocytic leukemia.
Published in:
Nature Communications, 2017, v. 8, n. 1, p. 1, doi. 10.1038/s41467-017-00210-6
By:
- Knittel, Gero;
- Rehkämper, Tim;
- Korovkina, Darya;
- Liedgens, Paul;
- Fritz, Christian;
- Torgovnick, Alessandro;
- Yussor Al-Baldawi, Yussor;
- Al-Maarri, Mona;
- Yupeng Cun;
- Fedorchenko, Oleg;
- Riabinska, Arina;
- Beleggia, Filippo;
- Nguyen, Phuong-Hien;
- Wunderlich, F. Thomas;
- Ortmann, Monika;
- Montesinos-Rongen, Manuel;
- Tausch, Eugen;
- Stilgenbauer, Stephan;
- Frenzel, Lukas P.;
- Herling, Marco
Publication type:
Article
Efficacy of phosphatidylinositol-3 kinase inhibitors with diverse isoform selectivity profiles for inhibiting the survival of chronic lymphocytic leukemia cells.
Published in:
International Journal of Cancer, 2015, v. 137, n. 9, p. 2234, doi. 10.1002/ijc.29579
By:
- Göckeritz, Elisa;
- Kerwien, Susan;
- Baumann, Michael;
- Wigger, Marion;
- Vondey, Verena;
- Neumann, Lars;
- Landwehr, Thomas;
- Wendtner, Clemens M.;
- Klein, Christian;
- Liu, Ningshu;
- Hallek, Michael;
- Frenzel, Lukas P.;
- Krause, Günter
Publication type:
Article
Sustained NF-kappaB activity in chronic lymphocytic leukemia is independent of genetic and epigenetic alterations in the TNFAIP3 ( A20) locus.
Published in:
International Journal of Cancer, 2011, v. 128, n. 10, p. 2495, doi. 10.1002/ijc.25579
By:
- Frenzel, Lukas P.;
- Claus, Rainer;
- Plume, Nadine;
- Schwamb, Janine;
- Konermann, Carolin;
- Pallasch, Christian P.;
- Claasen, Julia;
- Brinker, Reinhild;
- Wollnik, Bernd;
- Plass, Christoph;
- Wendtner, Clemens-Martin
Publication type:
Article
Comparison of the in vitro effects of the anti-CD20 antibodies rituximab and GA101 on chronic lymphocytic leukaemia cells.
Published in:
British Journal of Haematology, 2011, v. 152, n. 3, p. 295, doi. 10.1111/j.1365-2141.2010.08428.x
By:
- Patz, Michaela;
- Isaeva, Polina;
- Forcob, Nche;
- Müller, Bianka;
- Frenzel, Lukas P.;
- Wendtner, Clemens-Martin;
- Klein, Christian;
- Umana, Pablo;
- Hallek, Michael;
- Krause, Günter
Publication type:
Article
Novel X-linked inhibitor of apoptosis inhibiting compound as sensitizer for TRAIL-mediated apoptosis in chronic lymphocytic leukaemia with poor prognosis.
Published in:
British Journal of Haematology, 2011, v. 152, n. 2, p. 191, doi. 10.1111/j.1365-2141.2010.08426.x
By:
- Frenzel, Lukas P.;
- Patz, Michaela;
- Pallasch, Christian P.;
- Brinker, Reinhild;
- Claasen, Julia;
- Schulz, Alexandra;
- Hallek, Michael;
- Kashkar, Hamid;
- Wendtner, Clemens-Martin
Publication type:
Article

Found: 13